TWST(Twist Bioscience Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-09-30 | FY 截至 2023-09-30 | FY 截至 2024-09-30 | FY 截至 2025-09-30 | FY 截至 2026-09-30 |
|---|---|---|---|---|---|
| 营业收入 | $203.56M | $245.11M | $312.97M | $376.57M | $459.43M |
| 毛利润 | $84.23M | $89.73M | $133.35M | $191.00M | $240.80M |
| 营业利润 | −$234.78M | −$217.16M | −$220.83M | −$136.26M | −$139.46M |
| 净利润 | −$217.86M | −$204.62M | −$208.73M | −$77.67M | −$130.20M |
| 经营现金流 | −$124.39M | −$142.47M | −$64.09M | −$47.63M | −$41.43M |
| 自由现金流 | −$226.24M | −$170.25M | −$69.17M | −$75.63M | −$89.01M |
| 摊薄每股收益 | $-4.04 | $-3.60 | $-3.60 | $-1.30 | $-2.08 |